“Antiproliferative activity of the bioactive compound from Silybum marianum in a human melanoma cell line with BRAF mutation: potential for therapeutic repurposing”, Rev Fitos, vol. 19, p. e1812, Jul. 2025, doi: 10.32712/2446-4775.2025.1812.